Trusted Resources: Education
Scientific literature and patient education texts
Evolving Landscape in the Management of Transthyretin Amyloidosis
source: Annals of Medicine
year: 2015
authors: Hawkins PN, Ando Y, Dispenzeri A, Gonzalez-Duarte A, Adams D, Suhr OB
summary/abstract:Transthyretin (TTR) amyloidosis (ATTR amyloidosis) is a multisystemic, multigenotypic disease resulting from deposition of insoluble ATTR amyloid fibrils in various organs and tissues. Although considered rare, the prevalence of this serious disease is likely underestimated because symptoms can be non-specific and diagnosis largely relies on amyloid detection in tissue biopsies. Treatment is guided by which tissues/organs are involved, although therapeutic options are limited for patients with late-stage disease. Indeed, enthusiasm for liver transplantation for familial ATTR amyloidosis with polyneuropathy was dampened by poor outcomes among patients with significant neurological deficits or cardiac involvement.
Hence, there remains an unmet medical need for new therapies. The TTR stabilizers tafamidis and diflunisal slow disease progression in some patients with ATTR amyloidosis with polyneuropathy, and the postulated synergistic effect of doxycycline and tauroursodeoxycholic acid on dissolution of amyloid is under investigation.
Another therapeutic approach is to reduce production of the amyloidogenic protein, TTR. Plasma TTR concentration can be significantly reduced with ISIS-TTRRx, an investigational antisense oligonucleotide-based drug, or with patisiran and revusiran, which are investigational RNA interference-based therapeutics that target the liver. The evolving treatment landscape for ATTR amyloidosis brings hope for further improvements in clinical outcomes for patients with this debilitating disease.
organization: University College, UK; Kumamoto University, Japan; Mayo Clinic, USA; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico; Université Paris-Sud, France; Umeå University, SwedenDOI: 10.3109/07853890.2015.1068949
read more full text
Related Content
-
Treatment Patterns and Health Care Resource Utilization Among Patients With Relapsed/Refractory Systemic Light Chain...Background: Treatment for patients with...
-
Efficacy of Different Modes of Fractional CO2 Laser in the Treatment of Primary Cutaneous Amyloidosis: A Randomized ...Background: Primary cutaneous amyloidos...
-
Wild Type Transthyretin Amyloidosis (ATTRwt): An OverviewWild-type ATTR is also referred to as AT...
-
How to Talk With Your Family About Your hATTR Amyloidosis Diagnosis?Talking to your family members about you...
-
Emerging Treatments for AmyloidosisAmyloidosis results from protein misfold...
-
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging In Cardiac Amyloido...Cardiac amyloidosis is a form of restric...
-
Systemic Amyloidosis With Gastrointestinal Involvement: Diagnosis From Endoscopic and Histological ViewsAmyloid tends to deposit in the gastroin...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.